Vir Biotechnology, Inc.
VIR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001706431
No open-market purchases or sales by Vir Biotechnology, Inc. insiders were filed in the last 90 days; 237 institutions reported holding it in 13F filings for Q2 2026, worth $1.49B in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Vir Biotechnology, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 213
- +2 vs. Q2 2025
- Shares held
- 107.0M
- −3.74M (−3.4%) vs. Q2 2025
- Total value
- $610.8M
- +$52.5M (+9.4%) vs. Q2 2025
- New holders
- 28
- 61 more added
- Sold out
- 26
- 81 more reduced
2 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VIR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 237 | $1.49B |
| Q1 2026 | 252 | $1.25B |
| Q4 2025 | 218 | $696.5M |
| Q3 2025 | 213 | $610.8M |
| Q2 2025 | 213 | $558.5M |
| Q1 2025 | 234 | $604.5M |
| Q4 2024 | 208 | $652.0M |
| Q3 2024 | 197 | $656.3M |
| Q2 2024 | 215 | $783.1M |
| Q1 2024 | 210 | $901.0M |
| Q4 2023 | 207 | $887.2M |
| Q3 2023 | 215 | $827.4M |
| Q2 2023 | 227 | $2.23B |
| Q1 2023 | 234 | $2.06B |
| Q4 2022 | 225 | $2.18B |
| Q3 2022 | 221 | $1.68B |
| Q2 2022 | 214 | $2.20B |
| Q1 2022 | 204 | $2.09B |
| Q4 2021 | 210 | $3.25B |
| Q3 2021 | 175 | $3.24B |
| Q2 2021 | 166 | $3.64B |
| Q1 2021 | 157 | $3.87B |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Vir Biotechnology, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Goldman Sachs Group Inc | 1,521,802 | $8.69M | 0.00% | +231,664+18.0% | Added |
| Standard Life Aberdeen plc | 1,526,265 | $8.71M | 0.01% | +519,374+51.6% | Added |
| Geode Capital Management, LLC | 2,246,222 | $12.8M | 0.00% | −6,198−0.3% | Reduced |
| OrbiMed Advisors LLC | 2,380,715 | $13.6M | 0.33% | 00.0% | Unchanged |
| Morgan Stanley | 2,689,118 | $15.4M | 0.00% | +1,055,428+64.6% | Added |
| Dimensional Fund Advisors LP | 2,978,871 | $17.0M | 0.00% | −29,084−1.0% | Reduced |
| FMR LLC | 3,637,130 | $20.8M | 0.00% | +78,475+2.2% | Added |
| State Street Corp | 5,241,293 | $29.9M | 0.00% | −13,419−0.3% | Reduced |
| Vanguard Group Inc | 12,799,381 | $73.1M | 0.00% | −427,685−3.2% | Reduced |
| ARCH Venture Management, LLC | 12,916,663 | $73.8M | 14.98% | 00.0% | Unchanged |
| BlackRock, Inc. | 15,967,656 | $91.2M | 0.00% | −185,534−1.1% | Reduced |
| SB Investment Advisers (UK) Ltd | 16,684,041 | $95.3M | 0.72% | 00.0% | Unchanged |
| Salzhauer Michael | 4,300 | – | – | +4,300 | New |
| Artisan Partners Limited Partnership | 0 | $0 | 0.00% | −791,611−100.0% | Sold out |
| Catalio Capital Management, LP | 0 | $0 | 0.00% | −388,303−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −250,000−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −234,614−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −217,355−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −59,670−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −56,730−100.0% | Sold out |
| Ieq Capital, LLC | 0 | $0 | 0.00% | −46,363−100.0% | Sold out |
| Vontobel Holding Ltd. | 0 | $0 | 0.00% | −45,356−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −34,743−100.0% | Sold out |
| Axq Capital, LP | 0 | $0 | 0.00% | −23,820−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −22,527−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −19,802−100.0% | Sold out |
| Colony Group, LLC | 0 | $0 | 0.00% | −18,447−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −13,967−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −13,368−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −12,600−100.0% | Sold out |
| Ballentine Partners, LLC | 0 | $0 | 0.00% | −11,743−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −9,583−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −7,018−100.0% | Sold out |
| Leonteq Securities AG | 0 | $0 | 0.00% | −2,700−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −1,573−100.0% | Sold out |
| GHP Investment Advisors, Inc. | 0 | $0 | 0.00% | −734−100.0% | Sold out |
| MAI Capital Management | 0 | $0 | 0.00% | −124−100.0% | Sold out |
| Hughes Financial Services, LLC | 0 | $0 | 0.00% | −113−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −60−100.0% | Sold out |
| E Fund Management Co., Ltd. | – | – | – | – | Not filed |
| CIBC World Markets Corp | – | – | – | – | Not filed |